Latency and reservoirs for HIV-1.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  AIDS (London)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10885762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapid Clearance of Simian Immunodeficiency Virus Particles from Plasma of Rhesus Macaques

  1999cited by this paper
• HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy.

  1999cited by this paper
• Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

  1999cited by this paper
• Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

  1999cited by this paper
• HIV-1 Directly Kills CD4+ T Cells by a Fas-independent Mechanism

  1998cited by this paper
• A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.

  1998cited by this paper
• HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo

  1998cited by this paper
• HIV-protease inhibitors.

  1998cited by this paper
• HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

  1998cited by this paper
• Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.

  1998cited by this paper
• Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells.

  1998cited by this paper
• Viral dynamics in HIV-1 infection.

  1998cited by this paper
• A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA.

  1998cited by this paper
• SIV infection of macaques--modeling the progression to AIDS dementia.

  1998cited by this paper
• Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

  1998cited by this paper
• Vpr Stimulates Viral Expression and Induces Cell Killing in Human Immunodeficiency Virus Type 1-Infected Dividing Jurkat T Cells

  1998cited by this paper
• Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents.

  1998cited by this paper
• Drug concentration heterogeneity facilitates the evolution of drug resistance.

  1998cited by this paper
• Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy.

  1998cited by this paper
• Tat-Associated Kinase, TAK, Activity Is Regulated by Distinct Mechanisms in Peripheral Blood Lymphocytes and Promonocytic Cell Lines

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy.

  1998cited by this paper
• Macrophages as a source of HIV during opportunistic infections.

  1997cited by this paper
• Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest

  1997cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.

  1997cited by this paper
• Molecular mechanisms for the regulation of HIV replication, persistence and latency.

  1997cited by this paper
• Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain

  1997cited by this paper
• Infection of gastrointestinal tract macrophages by HIV‐1

  1997cited by this paper
• Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives

  1997cited by this paper
• Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons.

  1997cited by this paper
• Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

  1997cited by this paper
• Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

  1997cited by this paper
• T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen.

  1997cited by this paper
• Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

  1997cited by this paper
• Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

  1997cited by this paper
• Decay characteristics of HIV-1-infected compartments during combination therapy

  1997cited by this paper
• Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

  1997cited by this paper
• A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

  1997cited by this paper
• Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis.

  1997cited by this paper
• Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1

  1996cited by this paper
• Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection.

  1996cited by this paper
• Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control

  1996cited by this paper
• Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.

  1996cited by this paper
• Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes

  1996cited by this paper
• Phenotypic Analysis of Antigen-Specific T Lymphocytes

  1996cited by this paper
• Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.

  1996cited by this paper
• Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission

  1996cited by this paper
• Low infection frequency of macrophages in the spleens of HIV+ patients.

  1996cited by this paper
• HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

  1996cited by this paper
• The role of CD4 in HIV envelope-mediated pathogenesis.

  1996cited by this paper
• Human immunodeficiency virus and the brain.

  1996cited by this paper
• The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle

  1995cited by this paper
• Viral dynamics in human immunodeficiency virus type 1 infection

  1995cited by this paper
• HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

  1995cited by this paper
• Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro

  1995cited by this paper
• Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

  1995cited by this paper
• In vivo estimates of division and death rates of human T lymphocytes.

  1995cited by this paper
• In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

  1995cited by this paper
• Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

  1995cited by this paper
• Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells

  1995cited by this paper
• The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection

  1995cited by this paper
• Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts.

  1994cited by this paper
• Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status.

  1994cited by this paper
• Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry.

  1993cited by this paper
• High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

  1993cited by this paper
• Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

  1993cited by this paper
• Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys

  1993cited by this paper
• HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

  1993cited by this paper
• High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees

  1993cited by this paper
• Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction.

  1992cited by this paper
• Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1.

  1992cited by this paper
• Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.

  1992cited by this paper
• Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency

  1992cited by this paper
• Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease

  1992cited by this paper
• Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.

  1991cited by this paper
• Disturbance of nuclear transport of proteins in CD4+ cells expressing gp160 of human immunodeficiency virus

  1991cited by this paper
• The cytopathic effect of HIV is associated with apoptosis.

  1991cited by this paper
• Molecular basis of latency in pathogenic human viruses.

  1991cited by this paper
• Lymphoid organs function as major reservoirs for human immunodeficiency virus.

  1991cited by this paper
• Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.

  1991cited by this paper
• HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

  1990cited by this paper
• Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

  1990cited by this paper
• Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein

  1990cited by this paper
• Regulation of HIV-1 gene expression.

  1990cited by this paper
• Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers

  1990cited by this paper
• High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients

  1990cited by this paper
• An inducible transcription factor activates expression of human immunodeficiency virus in T cells

  1990cited by this paper
• Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

  1989cited by this paper
• Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

  1989cited by this paper
• Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression

  1989cited by this paper
• Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

  1989cited by this paper
• The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4.

  1989cited by this paper
• Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals

  1989cited by this paper
• Contingent genetic regulatory events in T lymphocyte activation.

  1989cited by this paper
• Plasma viremia in human immunodeficiency virus infection.

  1989cited by this paper
• HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation.

  1988cited by this paper
• The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV.

  1988cited by this paper
• Human immunodeficiency virus long terminal repeat responds to T-cell activation signals.

  1987cited by this paper
• Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.

  1987cited by this paper

• Macrophage-Derived Factors with the Potential to Contribute to the Pathogenicity of HIV-1 and HIV-2: Roles of M-CSF and CXCL7

  2025cites this paper
• Macrophage-Derived Factors with the Potential to Contribute to Pathogenicity of HIV-1 and HIV-2: Role of CCL-2/MCP-1

  2023cites this paper
• Antiretroviral Drug-Resistance Mutations on the Gag Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure

  2022cites this paper
• Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure

  2021cites this paper
• HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus

  2019cites this paper
• HIV infection alters the human epigenetic landscape

  2018cites this paper
• HIV Infection and AIDS

  2017cites this paper
• MESSA A PUNTO DI TEST ALTERNATIVI PER LO SCREENING DI POTENZIALI INIBITORI DELLA PROTEASI DI HIV-1

  2014cites this paper
• Global HIV/AIDS Clinical and Translational Pharmacology

  2012cites this paper
• HIV Type-1 Latency: Targeted Induction of Proviral Reservoirs

  2009cites this paper
• Tissue-Specific Sequence Alterations in the Human Immunodeficiency Virus Type 1 Envelope Favoring CCR5 Usage Contribute to Persistence of Dual-Tropic Virus in the Brain

  2009cites this paper
• HIV-1 Sequence Diversity as a Window Into HIV-1 Biology

  2008cites this paper
• Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1

  2008cites this paper
• Published Ahead of Print 2 Immunodeficiency Cell Reservoir of Human Characterization of the Follicular Dendritic Supplemental Material

  2008cites this paper
• Boosting protease inhibitors with low-dose ritonavir - unravelling the mystery

  2006cites this paper
• A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway.

  2005cites this paper
• Impact of Practice Changes on an Antiretroviral Budget in an HIV Care Program

  2005cites this paper
• Relationship between Changes in Thymic Emigrants and Cell-Associated HIV-1 Dna in HIV-1-Infected Children Initiating Antiretroviral Therapy

  2005cites this paper
• An anti-CD45RO immunotoxin kills HIV-latently infected cells from individuals on HAART with little effect on CD8 memory.

  2004cites this paper
• Multiple residues in the extracellular domains of CCR3 are critical for coreceptor activity.

  2004cites this paper
• Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.

  2004cites this paper
• Zidovudine, Lamivudine, and Abacavir Have Different Effects on Resting Cells Infected with Human Immunodeficiency Virus In Vitro

  2004influential citation
• Simplifying antiretroviral therapy.

  2004cites this paper
• NATURAL SELECTION AND THE ORGAN-SPECIFIC DIFFERENTIATION OF HIV-1 V3 HYPERVARIABLE REGION

  2004cites this paper
• Erworbenes Immunschwächesyndrom (Aids)

  2004cites this paper
• NATURAL SELECTION AND THE ORGAN‐SPECIFIC DIFFERENTIATION OF HIV‐1 V3 HYPERVARIABLE REGION

  2004cites this paper
• On the Role of Interferon Regulatory Factors in HIV‐1 Replication

  2003cites this paper
• Resistance to apoptosis: mechanism for the development of HIV reservoirs.

  2003cites this paper
• P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals.

  2002cites this paper
• Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model.

  2002cites this paper
• Modulation of Human Immunodeficiency Virus 1 Replication by Interferon Regulatory Factors

  2002cites this paper
• An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons.

  2002cites this paper
• Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspective.

  2002cites this paper
• Reliable and reproducible LightCycler qPCR for HIV-1 DNA 2-LTR circles.

  2002cites this paper
• 1359 Modulation of Human Immunodeficiency Virus 1 Replication by Interferon Regulatory

  2002cites this paper
• Specificity Neurotropism Independent of Coreceptor from Brain and Lymphoid Tissues Predicts Immunodeficiency Virus Type 1 Isolates Macrophage Tropism of Human

  2001cites this paper
• The pathogenesis of HIV-1 infection.

  2001cites this paper
• Two long terminal repeat circles and persistent HIV-1 replication

  2001cites this paper
• Intensification of Antiretroviral Therapy

  2001cites this paper
• The potential role of interleukin-2 in HIV

  2001cites this paper
• Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity

  2001cites this paper
• Quantification of In Vivo Replicative Capacity of HIV‐1 in Different Compartments of Infected Cells

  2001cites this paper
• HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health

  2001cites this paper
• Transient rebound of plasma HIV-1 RNA is not followed by repopulation of the lymphoid compartment with HIV-1-infected cells.

  2000cites this paper
• HIV-1 entry - an expanding portal for drug discovery.

  2000cites this paper
• Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir

  2000cites this paper
• [Physiopathology and treatment of acquired immunodeficiency syndrome].

  2000cites this paper
• Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA

  2000cites this paper
• HIV in body ̄uids during primary HIV infection: implications for pathogenesis, treatment and public health

  year unknowncites this paper